G. ROSA, M. SANFILIPPO, V. VILARDI, P. ORFEI AND A. GASPARETTO Vecuronium bromide is a non-depolarizing neuromuscular blocking drug with a relatively short duration of action and minimal cardiovascular side-effects (Agoston et al., 1980; Fahey et al., 1981; Morris et al., 1983) . In this preliminary report we have studied the effects of vecuronium on intracranial pressure and cerebral perfusion pressure in 20 patients with intracranial space-occupying pathology.
PATIENTS AND METHODS
Twenty patients with cerebral tumours (and papilloedema) undergoing neurosurgical operations were included in the study. Premedication consisted of atropine 0.01 mg kg" 1 and phenobarbitone 1.5mgkg~l i.m. given approximately 45 min before operation. Anaesthesia was induced with thiopentone 5 mg kg" 1 and maintained with 66% nitrous oxide in oxygen supplemented with fentanyl O.Olmgkg" 1^1 . The trachea was intubated following a bolus of suxamethonium 1 mg kg" 1 and the lungs mechanically ventilated to ensure normocarbia (P&c Ot = 4.5 ±0.36 kPa).
All patients were monitored continuously: ECG, heart rate (HR), end-expired carbon dioxide concentration, intra-arterial pressure (IAP) and central venous pressure (CVP) referenced to heart level and their analogue waveforms displayed (Siemens Sirecust 404). Intracranial pressure (ICP) was measured using an extradural pressure transducer (Gaeltec ICT/b) which was calibrated before insertion, and the zero of which was checked in situ (Gaab et al., 1978) . It was placed via the first burr hole performed, for a length of 3 cm, and the output was amplified using the Gaeltec Amplifier 57/b.
At least 30 min after the administration of the suxamethonium, and when all the measured variables were stable, vecuronium 0.1 mg kg" 1 was administered i.v. over 30 s.
The end-expiratory carbon dioxide concentration, IAP, CVP and ICP were recorded continuously on a four-channel MFE 1400 polygraph recorder at a paper speed of 25 mm min" 1 . Recording started 5 min before the injection of the vecuronium to obtain control base-line data, and was continued for 10 min after the administration. The operative procedure re-commenced on completion of the recording: IAP, CVP, mean ICP and HR were displayed on the monitors thereafter. Cerebral perfusion pressure (CPP) was calculated as: CPP = MAP-ICP (Langfit, 1973) , where MAP was the mean arterial pressure.
Fisher's F test for variance analysis was applied to evaluate the statistical significance of the various indices. P < 0.05 was considered statistically significant.
RESULTS
The results and the statistical analyses of the data are shown in table I. Figure 1 represents the record obtained from the first patient. The injection of vecuronium decreased the average (± SEM) MAP from 75.00±2.1 mm Hg ("0" value) to 74.3 ± 1.9 mm Hg after 3 min, and to 73.8± 1.9 mm Hg after 10 min, with percent decreases of 1.00 % and l-7%» respectively. At the same times, mean CVP decreased on average from 4.7±0.6 mm Hg to 4.3 ±0.5 mm Hg (9.6%) and to 4.0±0.4 mm Hg (14.9%); mean ICP decreased from 12.2± 2.0mmHg to 11.9±1.9mmHg (2.9%) and to 11.6±1.8mmHg (4.9%), and CPP decreased from 62.8 ±2.3 mm Hg to 62.4 + 2.0 mm Hg (0.6%) and to 62.2±2.1 mm Hg (1.0%). HR was stable during the investigation.
DISCUSSION
The effects of neuromuscular blocking drugs on ICP and CPP are unclear because, in general, they have been studied during the induction of anaesthesia and on intubation of the trachea, when the cardiovascular effects of these manipulations interfere with the specific assessments of ICP and CPP (McLeskey et al., 1974; Lewelt, Moszynski and Kozniewska, 1976; Moss et al., 1978; Campkin and Turner, 1980; Samuels, 1980; Cottrell et al., 1983) .
In this preliminary report we have investigated the effects of vecuronium on ICP and on systemic haemodynamics. Vecuronium was administered when all the variables were stable with no external interference. The anaesthetic technique used (thipentone, high dose of fentanyl and modest hyperventilation) was able to control the intracranial volume-even in the absence of muscle relaxation: baseline ICP were generally low. The extradural measurement of ICP was necessary because, in our experience, few patients can be fitted with an intraventricular catheter before or during operation and, fortunately, it has been shown that extradural pressure correlates closely with intraventricular pressure over a wide range, both in animals and in clinical practice (McDowall, 1978) . The prinicpal disadvantages of extradural transducers are the problems of zero drift (solved using the Gaeltec transducer) and changes in calibration once in situ-particularly with prolonged use. Under the described conditions an i.v. bolus of vecuronium 0.1 mgkg" 1 produced negligible changes in the indices studied, an effect confirmed recently in cats by Giflfin and colleagues (1984) . The small decrease in ICP was probably a result of the decrease in the CVP which followed relaxation of the muscles and which permitted better drainage of cerebral venous blood. MAP and the HR remained stable following the administration of vecuronium, as has been reported by others (Marshall, 1979; Lienhart et al., 1983; Morris et al., 1983) .
Our results suggest that vecuronium is a safe neuromuscular blocking drug for use in neuroanaesthesia and neurological intensive care on account of this lack of adverse effects on cerebral and systemic haemodynamics. The importance of haemodynamic stability in patients with a low cerebral compliance has been emphasized recently (Rosner and Becker, 1984) . The relatively short duration of action, and the rapid return of muscle tone, are relative disadvantages of vecuronium: repeated administration will be required (Buzello and Noldge, 1982) during longer operations and, if care is not taken, the patient may be capable of coughing vigorously during the surgical procedure.
